arrow
A

Andrew M. Demchuk

University of Calgary
H指数:113
被引数:6.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the Impact of a System-Wide Prehospital Teleconsultation on Rural Stroke Transportation Efficiency

评估系统级院前远程会诊对农村卒中转运效率的影响

2026-05-010
PRE
CT Angiography-for-All: Beyond Diagnostic Nihilism in Acute Intracerebral Hemorrhage Care - A Personal View

CT血管成像全覆盖:急性脑出血护理中的超越诊断虚无主义——个人观点

2025-12-010
PRE
The intracerebral hemorrhage checklist

颅内出血检查清单

2025-11-030
PRE
Initial intraventricular involvement and early intracerebral hematoma retraction: The “ventricular washout”

室管膜初始受累和早期颅内血肿退缩:所谓的“脑室冲洗”

2025-04-020
PRE
Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天时改良Rankin量表与24小时时美国国立卫生研究院卒中量表作为急性卒中试验的主要结局

2025-02-190
OAAI
Modified Rankin Score at 90 Days vs. NIH Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天改良Rankin评分与24小时NIH卒中量表作为急性卒中试验的主要结局指标

STROKE
IF8.9
2025-02-010
PRE
Co-localization of NCCT hypodensity and CTA spot sign to predict intracerebral hematoma expansion and severity: development and validation of the Black,-&-White sign

NCCT低密度与CTA点征的共定位预测颅内血肿扩大和严重程度:Black,-&-White征象的开发与验证

STROKE
IF8.9
2025-02-010
PRE
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial

影响ESCAPE-NA1试验中未接受阿替普酶治疗患者神经调节蛋白1疗效的临床因素

stroke
IF8.6
2025-01-310
OA
Thrombolysis in Patients With Versus Without Visible Occlusion: A Secondary Analysis From the AcT Trial

与无可见闭塞患者相比,有可见闭塞患者的溶栓治疗:来自AcT试验的二次分析

stroke
IF8.6
2025-01-310
OA
Validation of the Black-&-White sign to predict intracerebral hematoma expansion in the multi-center PREDICT study cohort
2025-01-100
PRE
Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial
2025-01-070
PRE
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 Trial
STROKE
IF8.9
2025-01-010
PRE
The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial
2024-09-110
PRE